Professor Chiu is a pediatrician and has finished his Ph.D. training at Imperial College London. He is a co-principal investigator of a birth cohort study in the Prediction of Allergies in Taiwanese Children (PATCH) joint study, initiating since 2007 to investigate the epidemiology and predictive factors of asthma and allergies in Taiwanese children. Many clinical studies regarding this birth cohort have been done and published. In addition, his research interests have long been involved in genomics, proteomics, microbiomics, metabolomics, and biological sciences for pediatric diseases. Current research works in his laboratory focus on three main pulmonary diseases including asthma, bronchopulmonary dysplasia, and spontaneous pneumothorax in children. The major study field of his research is now to apply metabolomics techniques by using 1H-NMR spectroscopy for further understanding the development of complex pediatric atopic diseases such as asthma and atopic dermatitis to provide protective or therapeutic strategies in clinics.
Professor Chiu is a pediatrician and has finished his Ph.D. training at Imperial College London. He is a co-principal investigator of a birth cohort study in the Prediction of Allergies in Taiwanese Children (PATCH) joint study, initiating since 2007 to investigate the epidemiology and predictive factors of asthma and allergies in Taiwanese children. Many clinical studies regarding this birth cohort have been done and published. In addition, his research interests have long been involved in genomics, proteomics, microbiomics, metabolomics, and biological sciences for pediatric diseases. Current research works in his laboratory focus on three main pulmonary diseases including asthma, bronchopulmonary dysplasia, and spontaneous pneumothorax in children. The major study field of his research is now to apply metabolomics techniques by using 1H-NMR spectroscopy for further understanding the development of complex pediatric atopic diseases such as asthma and atopic dermatitis to provide protective or therapeutic strategies in clinics.